Company / Return on Assets (ROA)
TG Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
42.1%
FY2025
5-year range
-115.6% / 42.1%
FY2021-FY2025
Trend
+938.5%
vs FY2024
Sector context
#3 of 213
Health Care
What the data says
Return on Assets (ROA) changed +939% YoY in FY2025, a notable deviation from the 9-year average annual change of +109%.
Based on SEC 10-K filings.
42.1% in FY2025 with a 5-year CAGR of +86.7%. Ranks 3rd among 213 companies in Health Care.
Improved from 3.8% to 42.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +157.7pp
- 5-Year Change
- +86.7pp
- 10-Year Change
- -
Sector benchmark
Top 1% in Health CareTop 1% of 213This company 42.1% Sector average -24.1%
▼
+274.2% above sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 938.5% year-over-year.
- Currently 66.2pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 42.1% | +938.5% |
| FY2024 | 4.0% | +5.5% |
| FY2023 | 3.8% | +103.3% |
| FY2022 | -115.6% | -26.1% |
| FY2021 | -91.7% | -105.3% |
| FY2020 | -44.7% | +38.6% |
| FY2019 | -72.7% | -46.3% |
| FY2018 | -49.7% | +59.2% |
| FY2017 | -121.7% | +14.8% |
| FY2016 | -142.9% | -157.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026